Effect of prior intensive therapy in type 1 diabetes on 10-year progression of retinopathy in the DCCT/EDIC: comparison of adults and adolescents. - Wikidata - awgldk - TriplyDB

Effect of prior intensive therapy in type 1 diabetes on 10-year progression of retinopathy in the DCCT/EDIC: comparison of adults and adolescents.

Effect of prior intensive therapy in type 1 diabetes on 10-year progression of retinopathy in the DCCT/EDIC: comparison of adults and adolescents.

http://www.wikidata.org/entity/Q33803493

about

Diabetic Macular Edema Long-term Outcomes in Youths with Diabetes Mellitus Insulin use and risk of diabetic macular edema in diabetes mellitus: a systemic review and meta-analysis of observational studies Protocol for systematic review of evidence on the determinants and influence of early glycaemic control in childhood-onset type 1 diabetes Diabetic retinopathy and systemic factors Role of mitochondria biogenesis in the metabolic memory associated with the continued progression of diabetic retinopathy and its regulation by lipoic acid Differential Response to High Glucose in Skin Fibroblasts of Monozygotic Twins Discordant for Type 1 Diabetes Changes in management and outcomes for children and adolescents with type 1 diabetes over the last 50 years.Diabetic macular edema: new concepts in patho-physiology and treatment.Medical management of diabetic retinopathy: fenofibrate and ACCORD Eye studies.Improving glycaemic control and life skills in adolescents with type 1 diabetes: a randomised, controlled intervention study using the Guided Self-Determination-Young method in triads of adolescents, parents and health care providers integrated into Managing diabetic macular edema: The leading cause of diabetes blindness Targeting intensive versus conventional glycaemic control for type 1 diabetes mellitus: a systematic review with meta-analyses and trial sequential analyses of randomised clinical trials.Improved metabolic control in children and adolescents with type 1 diabetes: a trend analysis using prospective multicenter data from Germany and Austria.Prevalence, Demographics, and Treatment Characteristics of Visual Impairment due to Diabetic Macular Edema in a Representative Canadian Cohort.Optimal treatment of diabetic retinopathy.A1C variability as an independent risk factor for microalbuminuria in young people with type 1 diabetes.Skin advanced glycation end products glucosepane and methylglyoxal hydroimidazolone are independently associated with long-term microvascular complication progression of type 1 diabetes.Community screening for pre-diabetes and diabetes using HbA1c levels in high-risk African Americans and Latinos.The association of previously reported polymorphisms for microvascular complications in a meta-analysis of diabetic retinopathy.Effect of intensive diabetes therapy on the progression of diabetic retinopathy in patients with type 1 diabetes: 18 years of follow-up in the DCCT/EDIC The prognosis of diabetic retinopathy in patients with type 2 diabetes since 1996-1998: the Skaraborg Diabetes Register.A five-year prospective study of diabetic retinopathy progression in chinese type 2 diabetes patients with "well-controlled" blood glucose.Symptoms of Eating Disorders and Depression in Emerging Adults with Early-Onset, Long-Duration Type 1 Diabetes and Their Association with Metabolic Control.Practical strategies to enhance executive functioning and strengthen diabetes management across the lifespan.INTEGRITY OF OUTER RETINAL LAYERS AFTER RESOLUTION OF CENTRAL INVOLVED DIABETIC MACULAR EDEMA.Regional differences in clinical care among patients with type 1 diabetes in Brazil: Brazilian Type 1 Diabetes Study Group.The association between skin collagen glucosepane and past progression of microvascular and neuropathic complications in type 1 diabetes.Assessing progress in retinopathy outcomes in type 1 diabetes: comparing findings from the Wisconsin Diabetes Registry Study and the Wisconsin Epidemiologic Study of Diabetic Retinopathy Diabetes care, glycemic control, complications, and concomitant autoimmune diseases in children with type 1 diabetes in Turkey: a multicenter study.Early electrophysiological abnormalities and clinical neuropathy: a prospective study in patients with type 1 diabetes.HbA1c: a review of analytical and clinical aspects.Diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: advances and contributions.The Role of DNA Methylation in the Metabolic Memory Phenomenon Associated With the Continued Progression of Diabetic Retinopathy.Impact of a first-year student pharmacist diabetes self-care education program.Partnering with diabetes educators to improve patient outcomes.Microvascular disease in children and adolescents with type 1 diabetes and obesity.The path to approval of new drugs for diabetes.Hyperglycemia and vascular metabolic memory: truth or fiction?Chromium does not belong in the diabetes treatment arsenal: Current evidence and future perspectives.

P2860

Q26749438-4FE5BB77-D115-4C99-B906-56D37A820FDC Q26799531-367BBBD1-EB23-4743-AAC9-5633B46F5940 Q27010850-7E3E0318-61E2-49B5-BF64-92595CFFFDD4 Q28082045-33E55EAB-E7EE-4FE3-AC66-C38DD3AA809D Q28082046-37A6B622-58A3-420D-B90C-67B0A9966858 Q28566371-CBE6498F-1BB3-4A9B-AF3F-B03DA0505D2D Q30300141-1B4EEFDC-6E1C-48D7-8326-54ABCFD92348 Q30369998-7CCCBCED-C16C-425F-AF3B-2A2035606B59 Q33713517-81954307-9826-4015-B2FE-0DC8F9B89476 Q33855386-E3900B3D-778B-4E93-A60F-70A5347F629A Q33932306-6F25DE48-62B8-4139-92BB-9484E1111405 Q34000861-217E7273-57A4-4DBD-8604-4A4B990A4615 Q34071861-8AF91032-4124-48CB-904E-4D7074CDB38E Q34072355-611293D8-E2C0-45B9-9728-DA2719ED3A7B Q34543471-C8B564B4-5059-48B0-B318-5C7BC14797AB Q34693503-11C52E6F-759F-46E6-8A40-BAFCCDA85C2C Q34718250-C3A2A043-1645-46B1-BD76-BA8814A3EA1C Q34762475-465A4182-F741-41A5-BAF8-5028920B43E1 Q34873090-AE8241C7-B93F-4C21-9E0D-1A2970751D28 Q34924454-ED847FD4-B639-40AF-998A-9F6EB3D7FC2A Q35004314-F46845F4-AA87-40FD-8B06-F9C9EDE2692E Q35229103-BD934855-C5A6-4EC6-9CEB-C52BFD10816F Q35300956-326B922E-839F-48BD-9AAB-08B956AEBF02 Q35677081-182FCE71-5A88-4308-8BE8-2E86CF213B01 Q35845622-2D330020-D14E-4331-8E67-9D679C1DFEC6 Q36250553-0CBBE84D-8C83-4024-938F-956D0D009628 Q36513518-7FD35B7C-9B8D-428B-8652-11FECBCCFFD7 Q36625195-5564C0DF-8A76-44F9-8FC7-C9AD92DF6993 Q36629520-1107DE34-7735-46CE-A701-E0602688863F Q36772146-18A1955E-BB61-4979-90E8-A876C890C337 Q37193421-08E11FB3-3AF9-4B10-BC4B-ACC54B61786B Q37284952-7BD762B6-B564-4A13-AE1E-C9B20A4C8C75 Q37333543-3151580E-0E54-401F-9FAC-A6E31A01C9EC Q37384357-F4FCC97B-C32D-4584-B512-42FD141D03B4 Q37414327-28A5794E-EE72-48DE-AAD8-F90872D511AB Q37589019-E7F0EBB4-905D-438C-BEDC-A6A590E89DBF Q37780987-57AC0ED2-55F8-43E0-97B4-CC5659E0C228 Q38080152-CB2B7482-0539-45C8-A374-FE6CC9E7E60D Q38086111-CF4AF676-DBC9-413A-9F2D-CBCB9CECB6BE Q38205764-E4331A22-0E67-4138-B038-E2C84E09B92D

P2860

Effect of prior intensive therapy in type 1 diabetes on 10-year progression of retinopathy in the DCCT/EDIC: comparison of adults and adolescents.

http://www.wikidata.org/entity/Q33803493

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Effect of prior intensive ther ...... son of adults and adolescents.

@ast

Effect of prior intensive ther ...... son of adults and adolescents.

@en

type

label

Effect of prior intensive ther ...... son of adults and adolescents.

@ast

Effect of prior intensive ther ...... son of adults and adolescents.

@en

prefLabel

Effect of prior intensive ther ...... son of adults and adolescents.

@ast

Effect of prior intensive ther ...... son of adults and adolescents.

@en

P1433

Q33803493-2C607A69-123A-40D5-9BD1-54535C314FB9

P1476

Q33803493-C790BD30-3E6B-4D50-88D7-1B256842F4C9

P2093

Q33803493-0ADE6440-FB04-44BD-AAE5-A397FB8D67A3

Q33803493-1D524141-D30B-4D3F-AADC-D03B2863ACAE

Q33803493-21D1FABB-4A33-4808-89E9-B515A2B6F652

Q33803493-37BA5350-A879-427C-AC45-DDB41CB86C0D

Q33803493-A072ED0F-7458-4895-8E50-4B46E678839F

Q33803493-C4EE98C3-C114-42E0-881E-4A58F1468042

Q33803493-E2839F4F-DDCE-4DBD-9294-7BFD6298C6CA

P2860

Q33803493-277D5BA9-CD99-4525-BD21-82375D3C55F0

Q33803493-3104A562-B657-4A6A-927E-BC51FE4143DF

Q33803493-4A328808-4698-4397-B4E1-FAF005E4F227

Q33803493-5164EFBC-7E79-4CCC-A897-8EDFB4CE946F

Q33803493-563A6780-7742-4249-90D0-032AE6238827

Q33803493-7DE2ABB5-B173-4A34-BB03-6ECAD377D2FE

Q33803493-8C093B4C-1AA8-430F-9BD2-6EAD7D56D8B7

Q33803493-94699FA0-B9CD-4267-A3E2-7338F8824173

Q33803493-BD82FCF9-7457-492F-A4DD-1386E020AFBF

Q33803493-BF808A2D-024B-4BDB-8AFE-EAA20B556055

P304

Q33803493-C03FB863-5BC9-4BEA-A61D-FC0928052D09

P31

Q33803493-1284424F-6605-48F3-A240-8AB505026EC9

P356

Q33803493-3987D695-2012-4155-9D57-B14B99B58FA4

P407

Q33803493-87C80CD1-A278-46C8-92C1-24FAD1FA5422

P433

Q33803493-56EB4B97-19BE-40BE-9B4A-7F82F105E960

P478

Q33803493-9FA187E4-05B7-49A8-A32E-240FEAF787DA

P50

Q33803493-CC454519-93EC-4536-81EB-57CD4FC53EBF

P577

Q33803493-68B66F57-52A9-4789-925B-8ADD30267C70

P5875

Q33803493-7574AFAF-DC4C-41E2-B983-56204959034C

P698

Q33803493-F1644585-58C9-4F30-90FE-7C782E8654A0

P921

Q33803493-5FAA4134-6A3A-44C3-B8EC-B70E7D89D19C

Q33803493-882CC420-5071-4F52-B7BA-EF96999F04EA

P932

Q33803493-252DD5AA-3634-4DEC-90A8-A7F198B06C4F

P356

P1433

P1476

Effect of prior intensive ther ...... son of adults and adolescents.

@en

P2093

DCCT-EDIC Research Group

http://www.w3.org/2001/XMLSchema#string

Dean P Hainsworth

http://www.w3.org/2001/XMLSchema#string

Matthew D Davis

http://www.w3.org/2001/XMLSchema#string

Neil H White

http://www.w3.org/2001/XMLSchema#string

Patricia A Cleary

http://www.w3.org/2001/XMLSchema#string

Ronald P Danis

http://www.w3.org/2001/XMLSchema#string

Wanjie Sun

http://www.w3.org/2001/XMLSchema#string

P2860

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy.

Maximum likelihood estimation for interval-censored data using a Weibull-based accelerated failure time model.

Parametric survival models for interval-censored data with time-dependent covariates.

Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT S

Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complicat

Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study.

Hemoglobin A1c measurements over nearly two decades: sustaining comparable values throughout the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications study.

Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial

Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging.

P304

1244-1253

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DB09-1216

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

59

http://www.w3.org/2001/XMLSchema#string

P50

William V Tamborlane

P577

2010-02-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41424693

http://www.w3.org/2001/XMLSchema#string

P698

20150283

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

P932

2857905

http://www.w3.org/2001/XMLSchema#string